Clinical Trial

Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients

Study acronym: OPTIJIROVEC
Recruiting
View on ClinicalTrials.gov →
Summary
Evaluate new diagnostic methods using qPCR on non-invasive samples, compared with reference techniques for the positive diagnosis of pneumocystis (PcP) in immunocompromised patients
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-17.
Status change: Not Yet Recruiting → Recruiting 2026-04-22
Trial Details
NCT Number NCT06890078
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Conditions Pneumocystis, Immunocompromised Patients
Enrollment 240 participants
Start Date 2025-07-08
Primary Completion 2027-07-08 (estimated)
Study Completion 2027-07-08 (estimated)
Updated on ClinicalTrials.gov 2026-04-23